ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
Clinical Evaluation of ExoDx™ Prostate (IntelliScore) in Men With Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy
Sponsor: Exosome Diagnostics, Inc.
Terminated
project reprioritization
A observational or N/A phase clinical study on Prostate Cancer, this trial is terminated or withdrawn. The trial is conducted by Exosome Diagnostics, Inc. and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2022 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Oct 2021 — Apr 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
-
May 2020 — Jul 2020 [monthly]
Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Exosome Diagnostics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .